NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Kintor Pharmaceutical Limited (HK: 9939)

 
9939 Technical Analysis
1.5
As on 30th May 2025 9939 STOCK Price closed @ 1.44 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.19 & Sell for SHORT-TERM with Stoploss of 1.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

9939STOCK Price

Open 1.44 Change Price %
High 1.48 1 Day 0.00 0.00
Low 1.41 1 Week 0.16 12.50
Close 1.44 1 Month 0.27 23.08
Volume 1741500 1 Year -0.56 -28.00
52 Week High 2.22 | 52 Week Low 0.81
 
HK Hong Kong Most Active Stocks
CSHK100 2041.18 -1.45%
1398 5.71 0.00%
1060 0.81 -5.81%
1093 8.10 6.30%
3988 4.56 -1.51%
43 1.14 0.00%
0939 7.04 0.28%
0857 6.59 -0.75%
1288 5.04 -0.40%
0460 0.98 3.16%
 
HK Hong Kong Top Gainers Stocks
8559 595.00 135127.27%
2211-OL 1.06 960.00%
2211 1.06 960.00%
1991 0.76 850.00%
0989 0.69 102.94%
1817 0.39 25.81%
1817 0.39 25.81%
2195 0.05 25.00%
0764 0.05 25.00%
2221 0.05 25.00%
 
HK Hong Kong Top Losers Stocks
2914 0.22 -100.00%
0106 0.01 -50.00%
0106 0.01 -50.00%
0876 0.01 -50.00%
0715 0.02 -33.33%
2310 0.02 -33.33%
2310 0.02 -33.33%
1293 0.09 -30.77%
1039 0.04 -20.00%
1269 0.04 -20.00%
 
 
9939
Daily Charts
9939
Intraday Charts
Whats New @
Bazaartrend
9939
Free Analysis
 
9939 Important Levels Intraday
RESISTANCE1.57
RESISTANCE1.53
RESISTANCE1.50
RESISTANCE1.48
SUPPORT1.40
SUPPORT1.38
SUPPORT1.35
SUPPORT1.31
 
9939 Forecast June 2025
4th UP Forecast2.96
3rd UP Forecast2.47
2nd UP Forecast2.17
1st UP Forecast1.87
1st DOWN Forecast1.01
2nd DOWN Forecast0.71
3rd DOWN Forecast0.41
4th DOWN Forecast-0.08
 
9939 Weekly Forecast
4th UP Forecast2.42
3rd UP Forecast2.11
2nd UP Forecast1.91
1st UP Forecast1.72
1st DOWN Forecast1.16
2nd DOWN Forecast0.97
3rd DOWN Forecast0.77
4th DOWN Forecast0.46
 
9939 Forecast2025
4th UP Forecast3.93
3rd UP Forecast3.13
2nd UP Forecast2.64
1st UP Forecast2.14
1st DOWN Forecast0.74
2nd DOWN Forecast0.24
3rd DOWN Forecast-0.25
4th DOWN Forecast-1.05
 
 
9939 Other Details
Segment EQ
Market Capital 13907534848.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
9939 Address
9939
 
9939 Latest News
 
Your Comments and Response on Kintor Pharmaceutical Limited
 
9939 Business Profile
Kintor Pharmaceutical Limited, a biopharmaceutical company, engages in the research and development of drugs for the treatment of various cancers and other androgen receptor (AR) - related diseases in China, the United States, and Taiwan. The company's lead drug candidates include Proxalutamide, a small molecule second generation AR antagonist that is in various clinical trials for metastatic castration-resistant prostate cancer and breast cancer, as well as for the treatment of COVID-19; and Pyrilutamide, which is in various clinical trials for androgenetic alopecia and acne vulgaris. It also develops ALK-1 for the treatment of metastatic hepatocellular carcinoma and liver cancer; Detorsertib, a second-generation mTOR inhibitor for the treatment of metastatic solid tumours; GT1708F for the treatment of leukaemia and basal-cell carcinoma; and GT20029 for the treatment of androgenetic alopecia and acne vulgaris. The company was founded in 2009 and is headquartered in Suzhou, China. Address: No. 20 Songbei Road, Suzhou, China, 215123
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service